X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3772) 3772
Publication (422) 422
Book Chapter (56) 56
Book Review (46) 46
Conference Proceeding (19) 19
Magazine Article (8) 8
Dissertation (7) 7
Government Document (7) 7
Book / eBook (4) 4
Newspaper Article (4) 4
Trade Publication Article (2) 2
Data Set (1) 1
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2281) 2281
index medicus (1540) 1540
animals (1529) 1529
bispecific antibody (1094) 1094
bispecific antibodies (1032) 1032
mice (977) 977
oncology (906) 906
antibodies, bispecific - immunology (823) 823
immunotherapy (778) 778
cancer (711) 711
antibodies, bispecific - therapeutic use (707) 707
immunology (677) 677
antibodies (584) 584
female (540) 540
monoclonal-antibody (444) 444
biochemistry & molecular biology (412) 412
therapy (390) 390
medicine, research & experimental (382) 382
cell line, tumor (370) 370
monoclonal-antibodies (362) 362
antibodies, bispecific - pharmacology (359) 359
t-lymphocytes - immunology (352) 352
monoclonal antibodies (346) 346
hematology (343) 343
cd3 complex - immunology (335) 335
expression (331) 331
antibodies, monoclonal - immunology (312) 312
viral antibodies (312) 312
antibodies, monoclonal - therapeutic use (311) 311
antibodies, bispecific - chemistry (307) 307
male (304) 304
proteins (304) 304
t-cells (289) 289
biotechnology & applied microbiology (288) 288
pharmacology & pharmacy (283) 283
tumors (276) 276
antibodies, bispecific - genetics (271) 271
neoplasms - immunology (253) 253
tumor cells, cultured (252) 252
cytotoxicity (240) 240
lymphocytes (239) 239
immunoglobulins (236) 236
antigens (235) 235
in-vivo (232) 232
neoplasms - therapy (231) 231
antigens, neoplasm - immunology (222) 222
antibodies, bispecific - metabolism (219) 219
immunotherapy - methods (219) 219
t cells (214) 214
activation (211) 211
article (204) 204
flow cytometry (204) 204
antibody specificity (202) 202
care and treatment (202) 202
research (201) 201
binding (197) 197
mice, inbred balb c (195) 195
antibody (193) 193
radioimmunotherapy (190) 190
health aspects (189) 189
cells (185) 185
protein engineering (184) 184
cytotoxicity, immunologic (179) 179
antibodies, bispecific - administration & dosage (176) 176
mice, nude (171) 171
antibodies, bispecific - biosynthesis (167) 167
biochemical research methods (167) 167
antigen (165) 165
tumor-cells (165) 165
molecular sequence data (161) 161
lymphoma (159) 159
middle aged (159) 159
adult (158) 158
analysis (155) 155
escherichia-coli (155) 155
single-chain antibody (155) 155
in-vitro (154) 154
leukemia (154) 154
growth-factor receptor (152) 152
antineoplastic agents - therapeutic use (151) 151
xenograft model antitumor assays (149) 149
amino acid sequence (148) 148
chemotherapy (146) 146
fragments (145) 145
lymphocytes t (145) 145
antibody engineering (144) 144
lymphocyte activation (143) 143
protein binding (143) 143
bispecific (142) 142
cell line (142) 142
enzyme-linked immunosorbent assay (140) 140
blinatumomab (136) 136
antibodies, bispecific - pharmacokinetics (135) 135
cell biology (135) 135
acute lymphoblastic-leukemia (134) 134
immunoglobulin g - immunology (134) 134
mice, scid (132) 132
receptor (132) 132
multidisciplinary sciences (130) 130
cancer-therapy (129) 129
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3733) 3733
Chinese (37) 37
German (29) 29
Japanese (17) 17
Russian (14) 14
French (8) 8
Czech (2) 2
Dutch (1) 1
Estonian (1) 1
Persian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 877 - 12
HIV-1 broadly neutralizing antibodies (bNAbs) are being explored as passively administered therapeutic and preventative agents. However, the extensively... 
BISPECIFIC ANTIBODIES | SHIV INFECTION | POTENT NEUTRALIZATION | BROADLY NEUTRALIZING ANTIBODIES | MULTIDISCIPLINARY SCIENCES | IMPROVES PROTECTION | CD4 BINDING | HUMAN MONOCLONAL-ANTIBODIES | HUMAN-IMMUNODEFICIENCY-VIRUS | FITNESS COST | BREADTH | Protein Subunits - immunology | env Gene Products, Human Immunodeficiency Virus - immunology | Antiviral Agents - immunology | Humans | Epitopes - immunology | Antibodies, Neutralizing - immunology | env Gene Products, Human Immunodeficiency Virus - genetics | HIV Antibodies - immunology | Antiviral Agents - chemistry | Antibodies, Neutralizing - therapeutic use | env Gene Products, Human Immunodeficiency Virus - antagonists & inhibitors | Drug Design | Single-Chain Antibodies - therapeutic use | HIV Antibodies - therapeutic use | HIV Antibodies - pharmacology | Antiviral Agents - pharmacology | Single-Chain Antibodies - pharmacology | Antiviral Agents - therapeutic use | HIV-1 - drug effects | Antibodies, Neutralizing - pharmacology | Epitopes - genetics | HIV-1 - genetics | Microscopy, Electron | HIV Antibodies - chemistry | HIV-1 - immunology | Antibodies, Neutralizing - chemistry | HIV Infections - drug therapy | Mutation | Drug Combinations | Single-Chain Antibodies - chemistry | Single-Chain Antibodies - immunology | Antiviral agents | Antibodies | Crosslinking | Glycoproteins | Pharmacology | Epitopes | Chemical compounds | Glycan | CD4 antigen | Human immunodeficiency virus--HIV | Avidity | Binding sites | Neutralization
Journal Article
Journal Article
Science, ISSN 0036-8075, 3/2009, Volume 323, Issue 5921, pp. 1610 - 1614
The interface between antibody and antigen is often depicted as a lock and key, suggesting that an antibody surface can accommodate only one antigen. Here, we... 
Antigens | Cell growth | DNA | Medical treatment | Antibodies | Amino acids | Reports | Breast cancer | Genetic mutation | Binding sites | Tumors | BREAST-CANCER | ANGSTROM RESOLUTION | COMPLEX | SOMATIC HYPERMUTATION | CRYSTAL-STRUCTURE | MULTIDISCIPLINARY SCIENCES | RECEPTOR | DIVERSITY | MOLECULAR-BASIS | ENDOTHELIAL GROWTH-FACTOR | XENOGRAFTS | Antibody Specificity | Complementarity Determining Regions - genetics | Epitopes - metabolism | Humans | Receptor, ErbB-2 - chemistry | Receptor, ErbB-2 - metabolism | Antibodies, Monoclonal - therapeutic use | Crystallography, X-Ray | Vascular Endothelial Growth Factor A - metabolism | Antibodies, Bispecific - genetics | Epitopes - immunology | Vascular Endothelial Growth Factor A - chemistry | Antibodies, Monoclonal, Humanized | Thermodynamics | Receptor, ErbB-2 - immunology | Antibodies, Monoclonal - chemistry | Antibodies, Monoclonal - immunology | Protein Structure, Tertiary | Binding Sites, Antibody - genetics | Models, Molecular | Antibody Affinity | Vascular Endothelial Growth Factor A - immunology | Antibodies, Bispecific - immunology | Xenograft Model Antitumor Assays | Antibodies, Bispecific - therapeutic use | Antibodies, Monoclonal - genetics | Animals | Genetic Engineering | Mutagenesis | Complementarity Determining Regions - immunology | Antibodies, Bispecific - chemistry | Protein Conformation | Cell Proliferation - drug effects | Mice | Neoplasms, Experimental - drug therapy | Trastuzumab | Viral antibodies | Therapeutics | Research | Properties | Vascular endothelial growth factor | Homeopathy | Materia medica and therapeutics | Proteins | Biotechnology | Cellular biology | Index Medicus
Journal Article
mAbs, ISSN 1942-0862, 02/2017, Volume 9, Issue 2, pp. 182 - 212
Journal Article
mAbs, ISSN 1942-0862, 02/2017, Volume 9, Issue 2, pp. 167 - 181
Journal Article
Trends in Biotechnology, ISSN 0167-7799, 2013, Volume 31, Issue 11, pp. 621 - 632
Journal Article
Science, ISSN 0036-8075, 10/2017, Volume 358, Issue 6359, pp. 85 - 90
Journal Article